The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...

Equities research analysts at Wedbush boosted their FY2024 EPS estimates for shares of Zentalis Pharmaceuticals in a research note issued to investors on Wednesday, January 29th. Wedbush analyst R.

Healthcare: With ultra-processed food consumption surging by 13.7 per cent between 2011 and 2021, and rural India now ...

Learn more about whether Alcon Inc. or Hologic, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price target lowered by HC Wainwright from $20.00 to $10.00 in a research report released on Wednesday,Benzinga reports. The firm currently ...

It can be awkward (picture an hourlong gynecological exam, but friendlier), but it’s an underrated option for perimenopausal ...

Learn more about whether AbbVie Inc. or Genmab A/S is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Use of long-acting, reversible contraceptives is associated with an increased risk of certain cancers, a study suggests.

(2004) women with myomas were more likely to report a "gushing"-type of bleeding and high pad/tampon use than women without myomas. [26] Additionally, women with uterine fibroids may suffer more ...

Ovarian cancer is the deadliest gynecologic malignancy globally and is increasing in incidence and mortality with currently ...

Bleacher Report’s Zachary D Rymer gave the signings an A grade. Under his system ... to have a better year because he had an overly high batting average on balls in play (BABIP), which can ...